Synthesis and anti-HIV activity of new C2 symmetric derivatives designed as HIV-1 protease inhibitors
The synthesis of several new anti-HIV-1 compounds is described. The new compounds contain a C2 symmetry axis and a dihidroxyethylene moiety based on the D-tartaric acid back bone. The synthesis of these compounds was achieved in 36-69% overall